Establishing a Novel Pyroptosis-related Gene Signature and Predicting Chemical Drugs for Papillary Thyroid Cancer
- PMID: 39492777
- DOI: 10.2174/0113892010325685241029113633
Establishing a Novel Pyroptosis-related Gene Signature and Predicting Chemical Drugs for Papillary Thyroid Cancer
Abstract
Background: The present study aimed to construct a novel pyroptosis-related gene signature to predict the prognosis of papillary thyroid cancer (PTC).
Methods: The gene expression level and survival and prognosis information of PTC were obtained from TCGA. The differentially expressed pyroptosis-related genes (DEPs) between cancer and control groups were selected, followed by subtype analysis. A prognostic model was built using LASSO regression analysis. The samples were then divided into high- and low-risk groups, and the differences in immune cell distribution in different risk groups were compared. The chemical drugs associated with genes in the prognostic model were extracted from the Comparative Toxicogenomics Database.
Results: A total of 31 DEPs were selected, and 3 different subtypes were obtained. A prognostic model based on 6 pyroptosis-related genes was constructed. The risk grouping was significantly correlated with the actual prognosis, and the model was found to be an independent prognostic factor. Six immune cells with significant differences in distribution in different risk groups were screened. CGP52608 could target four genes in the prognostic model, including GSDMB, NLRC4, IL1A, and IL6.
Conclusion: The present study constructed a pyroptosis-related gene signature that could predict the prognosis of PTC. Additionally, this signature was correlated with tumor immunity.
Keywords: Pyroptosis; gene; immune; papillary thyroid cancer; prognosis; signature..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.BMC Genomics. 2021 Jul 27;22(1):576. doi: 10.1186/s12864-021-07895-6. BMC Genomics. 2021. PMID: 34315405 Free PMC article.
-
Development and validation of a three-immune-related gene signature prognostic risk model in papillary thyroid carcinoma.J Endocrinol Invest. 2021 Oct;44(10):2153-2163. doi: 10.1007/s40618-021-01514-7. Epub 2021 Feb 23. J Endocrinol Invest. 2021. PMID: 33620716
-
Identification of a pyroptosis-related prognostic signature in breast cancer.BMC Cancer. 2022 Apr 20;22(1):429. doi: 10.1186/s12885-022-09526-z. BMC Cancer. 2022. PMID: 35443644 Free PMC article.
-
Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.Acta Biochim Biophys Sin (Shanghai). 2021 Dec 8;53(12):1579-1589. doi: 10.1093/abbs/gmab145. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 34693452
-
MicroRNA signature predicts survival in papillary thyroid carcinoma.J Cell Biochem. 2019 Oct;120(10):17050-17058. doi: 10.1002/jcb.28966. Epub 2019 May 17. J Cell Biochem. 2019. PMID: 31099134
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical